A Worked Pathway-Prior Analysis of Matched Omics Data

From Matched Measurements to Pathway Priors

A pathway prior is useful only when its biological meaning and statistical role are explicit. In this worked analysis, pathway membership changes how much effect variation the model expects before seeing the outcome-associated data. It does not force a member feature to have a nonzero effect, nor does membership establish that the pathway causes the outcome.

Consider a hypothetical study of 16 patients. RNA abundance and protein abundance are measured on the same patients, alongside a clinical outcome. For each molecular feature, a regression adjusted for age produces an estimated standardized association with the outcome, \(b_j\), and an estimated sampling variance \(v_j\). The standardized coefficient is in standard-deviation units of outcome per standard-deviation unit of feature. Suppose the estimates used below have \(v_j=0.15625\), so their standard error is \(\sqrt{0.15625}=0.3953\) standardized-effect units.

The measurements are matched because the same patients contribute to both molecular layers. Matching helps ensure that layer-specific estimates refer to the same study population, but it does not make the RNA and protein estimates independent. We first analyze each feature's marginal estimate; a joint analysis of several features would need to account for cross-feature covariance if that covariance is material.

The sampling model treats the reported estimate as approximately normal with known sampling variance. In practice, that approximation is most defensible when the regression estimator is approximately normal and its standard error is sufficiently well estimated. The prior variances are fixed for this illustration. They should be chosen or calibrated using relevant biological context and prior predictive assessment, not tuned merely to produce a desired posterior result.

Building the Membership Prior

To create \(g_j\), map the measured features to a pathway definition using identifiers and the appropriate molecular layer. For this hypothetical example, suppose the pathway database has already been filtered to the relevant tissue and context. Two measured features, transcript \(T_A\) and protein \(P_A\), are pathway members; transcript \(T_B\) is not. This is a simplified binary assignment. A real analysis should document how ambiguous identifiers, multiple pathway annotations, and uncertain membership are handled.

The assignment is a prior-model decision, not an observation of the outcome effect. Here it changes the prior variance from \(0.09\) for a nonmember to \(0.64\) for a member. Both priors remain centered at zero, so positive and negative effects are possible for either group. A membership-informed prior therefore represents a difference in expected effect scale, not a claim that all members are associated.

If membership itself is uncertain, one possible extension is a mixture prior. If \(q_j\) is the prior probability that feature \(j\) belongs to the pathway, assign probability \(q_j\) to \(N(0,\tau_1^2)\) and \(1-q_j\) to \(N(0,\tau_0^2)\). The prior predictive density of \(b_j\) is then a mixture of normal densities with variances \(v_j+\tau_1^2\) and \(v_j+\tau_0^2\). This retains membership uncertainty rather than converting weak evidence into a certain assignment. The worked calculations below use the simpler binary assignments.

Gaussian Updating and Its Justification

For a feature assigned prior variance \(\tau^2\), the likelihood and prior are both normal. Their product gives a normal posterior. The posterior mean is a weighted average of the observed estimate and the prior mean, which is zero here. The posterior variance is smaller than either variance separately because the likelihood and prior contribute information about the same effect.

For completeness, these expressions follow by collecting the terms involving \(\theta\) in the log of the likelihood times the prior. Ignoring constants that do not depend on \(\theta\), the exponent is

The coefficient of \(\theta^2\) is the posterior precision \(1/V\). Completing the square gives the center \(m=Vb/v\), yielding the stated posterior normal distribution. This also shows why the posterior mean is pulled toward zero: the prior contributes precision \(1/\tau^2\) centered at zero. With larger \(\tau^2\), the prior contributes less precision and the estimate is shrunk less.

Prior Predictive Checks

A prior predictive check asks what estimates the model could generate before conditioning on the observed estimate. For a fixed membership class, integrating over \(\theta_j\) gives \(b_j\sim N(0,\tau^2+v_j)\): the prior variance of the effect and the sampling variance add. This distribution can expose a prior that predicts effects far too small or large for the intended analysis.

If a membership prior predicts estimates that are implausibly extreme across many features, its variance may be too large; if it predicts nearly all estimates to be close to zero despite credible evidence for substantial effects, it may be too restrictive. Prior predictive checks assess consequences of prior choices. They are distinct from posterior predictive checks, which assess data replicated from a fitted posterior model.

Diagnostics, Alternatives, and Limits

The feature-wise Gaussian calculation is transparent, but its interpretation depends on the model being adequate. Check that features are mapped to the intended pathway and molecular layer; that the sampling variances reflect the matched study design and any covariate adjustment; and that the chosen prior scales produce reasonable prior predictions. Also inspect whether results change materially under scientifically defensible alternative prior scales. Sensitivity to those choices is important when the likelihood is weak.

A central limitation is the marginal treatment of features. If several features are analyzed jointly, correlated sampling errors or correlated true effects can make a product of independent feature likelihoods or priors inappropriate. A multivariate model can represent their covariance; alternatively, a carefully justified feature-wise analysis can report marginal results without making joint independence claims. Overlapping pathway memberships also require care: assigning a feature to several independent pathway priors and multiplying their contributions can count the same biological evidence more than once.

A frequent mistake is to read pathway membership as proof of an effect: “This feature is in the pathway, so its association must be real and positive.” The correction is that membership here changes the prior variance, while the prior mean remains zero and the likelihood still supplies the observed estimate. Another mistake is to call a 95% posterior interval a 95% confidence interval. The former summarizes uncertainty about the parameter conditional on the model and data; the latter is a repeated-sampling procedure with a different interpretation.